Con-sequins 2026: From mission to momentum

A foundational challenge of equity neuroscience is understanding how to move from describing inequitable neurological disparities to identifying the mechanisms, systems, and infrastructures needed to reduce them. The Society for Equity Neuroscience (SEQUINS) was founded in 2024 to advance brain health equity and reduce neurological disparities through science [1]. CON-Sequins '26, held on May 14, 2026, in Charleston, South Carolina, was the society's second annual meeting and reflected its expanding role as a scientific, educational, disseminative, and workforce-development platform. It convened investigators, clinicians, trainees, public health leaders, and community-engaged scholars from across the United States and beyond. Major scientific themes included social drivers of Alzheimer's disease and related dementias, upstream contributors to racial disparities in stroke, global neurology, cerebral malaria, global health security, translational science infrastructure, artificial intelligence, clinical trial representation, community-engaged research, and workforce development. Early career scholars presented their work in three distinct poster sessions. This proceedings report summarizes the conference program, emerging scholarship, workforce-development activities, dissemination efforts, participation metrics, and future priorities for the field. Con-Sequins '26 suggests that recurring convenings may provide a key mechanism for translating equity neuroscience from a conceptual framework into research, implementation, mentorship, and policy objectives.